help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, D.
Right arrow Articles by Eizirik, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, D.
Right arrow Articles by Eizirik, D. L.
Endocrinology Vol. 142, No. 6 2593-2599
Copyright © 2001 by The Endocrine Society


ARTICLES

Double-Stranded Ribonucleic Acid (RNA) Induces ß-Cell Fas Messenger RNA Expression and Increases Cytokine-Induced ß-Cell Apoptosis1

Dongbo Liu, Martine Darville and Décio L. Eizirik

Gene Expression Unit, Diabetes Research Center, Vrije Universiteit Brussel, B-1090 Brussels, Belgium

Address all correspondence and requests for reprints to: Dr. D. L. Eizirik, Gene Expression Unit, Diabetes Research Center, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. E-mail: deizirik{at}mebo.vub.ac.be


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Type 1 diabetes mellitus (T1DM) is an autoimmune disease caused by progressive destruction of insulin-producing pancreatic ß-cells. Both viral infections and the cytokines interleukin-1ß (IL-1ß) and interferon-{gamma} (IFN-{gamma}) have been suggested as potential mediators of ß-cell death in early T1DM. We presently investigated whether the viral replicative intermediate double stranded RNA [here used as synthetic polyinosinic-polycytidylic acid (PIC)] modifies the effects of IL-1ß and IFN-{gamma} on gene expression and viability of rat pancreatic ß-cells. For this purpose, fluorescence-activated cell sorting-purified rat ß-cells were exposed for 6–16 h (study of gene expression by RT-PCR) or 6–9 days (study of viability by nuclear dyes) to PIC and/or IL-1ß and IFN-{gamma}. PIC increased the expression of Fas and Mn superoxide dismutase messenger RNAs by 5- to 10-fold. IL-1ß and a combination of PIC and IFN-{gamma} (but not PIC or IFN-{gamma} alone) induced expression of inducible nitric oxide (NO) synthase (iNOS) and consequent NO production. Induction of iNOS expression by PIC and IFN-{gamma} requires nuclear factor-{kappa}B activation, as suggested by transfection experiments with iNOS promoter-luciferase reporter constructs into primary ß-cells. Combinations of IL-1ß plus IFN-{gamma}, PIC plus IFN-{gamma}, or PIC plus IL-1ß induced a 2- to 3-fold increase in the number of apoptotic ß-cells. Blocking of iNOS activity significantly decreased PIC- plus IL-1ß-induced, but not PIC- plus IFN-{gamma}-induced, apoptosis.

In conclusion, PIC alone or in combination with cytokines modifies the expression of several genes in pancreatic ß-cells. Two of these genes, Fas and iNOS, may contribute to ß-cell death. The transcription factor nuclear factor-{kappa}B is required for PIC-induced iNOS expression. PIC has an additive effect on cytokine-induced ß-cell death by both NO-dependent (in the case of IL-1ß) and NO-independent (in the case of IFN-{gamma}) mechanisms. These findings suggest that viral intermediates in synergism with local cytokine production may play an important role in ß-cell apoptosis in early T1DM.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
TYPE 1 DIABETES mellitus (T1DM) is caused by a progressive destruction of pancreatic ß-cells, leading to insulin deficiency (1, 2). There is extensive epidemiological evidence that viral infections may contribute for the pathogenesis of T1DM (3, 4), and several enteroviruses can infect human ß-cells, resulting in functional impairment or cell death (5).

A common pathway for viral-induced cellular responses is via the accumulation of double-stranded RNA (dsRNA) in the cytoplasm of eukaryotic cells (6). dsRNA can trigger apoptotic cell death (7), and several studies suggest that apoptosis is the main form of ß-cell death in animal models of T1DM and possibly also in human T1DM (reviewed in Refs. 8 and 9). Another potential mediator of ß-cell apoptosis is cytokines, peptides that may accumulate at high concentrations at the insulitis site. The cytokines interleukin-1ß (IL-1ß), tumor necrosis factor-{alpha}, and interferon-{gamma} (IFN-{gamma}) have been shown to induce rodent and human ß-cell death mostly by apoptosis (reviewed in Refs. 8 and 10, 11, 12, 13). Furthermore, cytokines and the inducible form of nitric oxide (NO) synthase (iNOS) are expressed in the vicinity of ß-cells during the induction of diabetes by the D variant of encephalomyocarditis virus in DBA/2 mice, and both antibodies against IL-1ß and iNOS blockers prevent the outbreak of diabetes in these mice (14). Finally, it has been shown that dsRNA [in the form of poly(IC)] inhibits glucose-stimulated insulin biosynthesis in mouse islets (15), and that exposure of rat pancreatic islets to dsRNA in combination with IFN-{gamma} leads to ß-cell dysfunction and death, apparently by an NO-dependent mechanism (16). No indication was provided in this later study of whether the ß-cells die by necrosis or apoptosis after exposure to dsRNA and IFN-{gamma} (16). Together the observations described above suggest that local induction of cytokines, perhaps triggered by a viral infection, may interact with viral products, such as dsRNA, leading to ß-cell death.

In the present study we investigated the effects of dsRNA [tested here as synthetic polyinosinic-polycytidylic acid (PIC)] alone or in combination with the cytokines IL-1ß and/or IFN-{gamma} on gene expression and viability of fluorescence-activated cell sorting (FACS)-purified rat ß-cells. The data obtained suggest that PIC contributes to the expression of genes that may participate in the induction of ß-cell death, such as Fas and iNOS. The main form of ß-cell death induced by combinations of PIC and cytokines is apoptosis, which occurs by both NO-dependent and -independent mechanisms.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
ß-Cell isolation and culture
Islets were isolated from male Wistar rats by collagenase digestion and dissociated into single cells in a calcium-free medium containing trypsin and deoxyribonuclease. Single ß-cells were subsequently purified by FACS using cellular light scatter and flavin adenine dinucleotide-autofluorescence as discriminating parameters. These preparations contain approximately 95% viable ß-cells (17). The purified ß-cells were cultured in Ham’s F-10 medium supplemented with 10 mM glucose, 50 µM 3-isobutyl-1-methylxanthine, 1% BSA (Roche Molecular Biochemicals, Mannheim, Germany), 0.1 mg/ml streptomycin (Continental Pharma, Puteaux, Belgium), 0.075 mg/ml penicillin (Laboratoires Diamant, Brussels, Belgium), and 2 mM L-glutamine (Life Technologies, Inc., Paisley, Scotland) (18). For viability experiments (see below), FACS-purified single ß-cells (3 x 103 cells/well) were cultured for 6–9 days in Falcon 96-well microtiter plates (Becton Dickinson and Co., Rutherford, NJ) containing 200 µl medium. Culture medium was changed every 3 days, and fresh cytokines were added. For messenger RNA (mRNA) determination the single ß-cells were reaggregated for 3 h in a rotary shaking incubator (19), cultured for 14–16 h in suspension (culture conditions as described above), and then exposed for 6 h to different combinations of cytokines and/or PIC.

PIC and cytokine treatment and nitrite determination
The effects of cytokines and/or PIC were examined after 6 h, 6 days, and 9 days of culture in the presence of recombinant murine IFN-{gamma} (1000 U/ml, 10 U/ng; Holland Biotechnology, Leiden, The Netherlands), recombinant human IL-1ß (50 U/ml, 38 U/ng; gift from Dr. C. W. Reynolds from NCI, Bethesda, MD), and synthetic PIC (100 µg/ml; Sigma, St. Louis, MO). The concentrations of cytokines were selected based on our previous studies with rodent pancreatic islets and ß-cells (11, 20, 21, 22), whereas the concentration of PIC was selected based on data from the literature (16, 23, 24) and our own dose-response studies (data not shown). Culture media were collected after 72 h for nitrite determination (nitrite is a stable product of NO oxidation), which was performed spectrophotometrically at 546 nm wavelength after colored reaction with the Griess reagent (25). Nitrite was not determined at subsequent time points because ß-cells exposed to PIC and cytokines for 6–9 days demonstrate an important decrease in viability (see Results). In some experiments ß-cells were exposed to cytokines and/or PIC in the presence of the iNOS inhibitor NG-monomethyl-L-arginine (MA; 1 mM). We have previously shown that 0.5–1.0 mM MA prevents cytokine-induced nitrite production by rat pancreatic ß-cells (19) (Pavlovic, D., and D. L. Eizirik, unpublished data).

mRNA isolation and RT-PCR
Polyadenylated RNA was isolated from ß-cells (0.5 x 105 cells) using oligo(deoxythymidine)25-coated polystyrene Dynabeads (DynAl, Oslo, Norway). The RT reaction was performed at 42 C for 1 h and contained (per 10 µl) mRNA equivalent to 6 x 103 cells, 1 x RT buffer, 5 mM MgCl2, 1 mM of each deoxy-NTP, 2.5 µM random hexamer primers, and 100 U Moloney murine leukemia virus reverse transcriptase (Perkin-Elmer Corp., Norwalk, CT). The subsequent PCR reaction contained (in 25 µl reaction solution): 2.5 µl complementary DNA (cDNA), 0.4 µM forward and reverse primers, 200 µM of each deoxy-NTP, 1 x PCR buffer, 2 mM MgCl2, and 0.625 U AmpliTaq Gold DNA polymerase (Perkin-Elmer Corp.) (22, 26). PCR specificity and efficiency were enhanced using hot start PCR with 12-min predenaturation at 95 C and then 29 cycles for glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 28 cycles for iNOS, 25 cycles for MnSOD (manganese superoxide dismutase), 36 cycles for Fas, 28 cycles for major histocompatibility complex (MHC) class I, and 33 cycles for Spi-3 (serine protease inhibitor 3) at 94 C for 45 sec, 58 C for 45 sec, and 72 C for 80 sec. The number of cycles was selected to allow linear amplification of the cDNA under study. The primer sequences used for determination of rat cDNAs for GAPDH, iNOS (20), MnSOD (27), and Spi-3 (28) were as described in the indicated references. The primer sequences used for determination of rat cDNAs for Fas were: forward, 5'-GAATGCAAGGGACTGATAGC-3'; and reverse, 5'-TGGTTCGTGTGCAAGGCTC-3'. The primer sequences used for determination of rat cDNAs for MHC I were: forward, 5'-GCTCACACTCGCTGCGGTAT-3'; and reverse, 5'-GCCATACATCTCCTGGATGG-3'.

The ethidium bromide-stained agarose gels were photographed under UV transillumination using Kodak Digital Science DC40 camera (Eastman Kodak Co., Rochester, NY). The PCR band intensities on the image were quantified by Biomax 1D Image analysis software (Kodak) and expressed in pixel intensities (OD). The target cDNAs present in each sample were corrected for the respective GAPDH values. Expression of the housekeeping gene GAPDH is not affected by exposure to cytokines (29).

Cell transfection and luciferase assay
Studies on iNOS promoter activity in single ß-cells (4 x 104 cells/condition) were performed by transient transfection with the plasmid piNOS-1002luc containing nucleotides -1002 to +132 of the rat iNOS promoter [wild-type (wt)] and mutants from piNOS-1002luc in which either the distal or proximal nuclear factor-{kappa}B (NF-{kappa}B)-binding sites, or the STAT (signal transducer and activator of transcription)-binding (GAS) {gamma}-interferon activated site, were inactivated (30). We previously observed that the promoter region containing nucleotides -1002 to +132 is required for maximal IL-1ß-induced iNOS activation in rat insulin-producing cells (30). ß-Cells were transfected with Lipofectamine (Life Technologies, Inc., Gaithersburg, MD). After 4-h transfection they were exposed for 16 h to cytokines and/or PIC. Luciferase activities were assayed with the dual luciferase reporter assay (Promega Corp.) in a TD-20/20 Luminometer (Turner Designs, Sunnyvale, CA). The values of the test plasmid were normalized for the luciferase activity value of the cotransfected control plasmid, pRL-CMV (30). The different conditions tested did not affect pRL-CMV activities, which for control, IFN-{gamma}- plus PIC-treated, and IL-1ß-treated ß-cells (means of three experiments) were 521, 549, and 646, respectively.

Note that the molecular biology experiments described above require large numbers of cells. As ß-cells are difficult to obtain, these experiments are usually performed in insulin-producing cell lines (27, 30). Unfortunately, neither RINm5F cells nor MIN6 cells are responsive to PIC-induced modifications in gene expression (data not shown). Thus, all of our experiments were performed with primary ß-cells.

Assessment of ß-cell viability
The percentage of viable, apoptotic, and necrotic ß-cells was determined after 6 or 9 days of exposure to cytokines and/or PIC, the amount of time required to detect significant increases in cell death in FACS-purified ß-cells (22, 31, 32) (data not shown). For this purpose, ß-cells were incubated for 15 min with propidium iodide (PI; 10 m/ml) and Hoechst (HO) 342 (20 mg/ml) (33). PI is a highly polar dye that penetrates only cells with damaged membranes, staining their nuclei red; HO 342 freely crosses the plasma membrane, entering both cells with damaged and those with intact membranes and staining the DNA blue (33). The cells were examined in an inverted fluorescence microscope with UV excitation at 340–380 nm. Viable cells were identified by their intact nuclei with blue fluorescence (HO 342), necrotic cells by their intact nuclei with yellow-red fluorescence (HO 342 and PI), and apoptotic cells by their fragmented nuclei, exhibiting either a blue (HO-342; early apoptosis) or yellow-red fluorescence (HO 343 and PI; late apoptosis) (33). Note that under the present experimental conditions (culture in serum-free medium), nuclear remains from cells undergoing apoptosis or necrosis are preserved, and the cells remain attached to the culture dish (33). Thus, the values provided in Figs. 4Go and 5Go represent the cumulative number of apoptotic or necrotic cells over a 6- to 9-day period of observation. This fluorescence assay for single ß-cells is quantitative and has been validated by systematic comparisons with electron microscopy observations (32, 33). The method has been successfully used to evaluate apoptosis/necrosis in rat (32, 33) (present data), mouse (22, 26), and human (31) ß-cells. The use of purified ß-cells in these experiments provides a homogeneous and well defined cell population (>95% ß-cells), decreasing the detection of cell death in non-ß-cells, a problem inherent to studies performed in whole isles. In each experimental condition, a minimum of 500 cells were counted by 2 observers, 1 of whom was unaware of the sample identity. The necrosis and apoptosis indexes were calculated as ((% necrotic or apoptotic cells in experimental condition - % necrotic or apoptotic cells in control)/(100 - % dead cells in control)) x 100 (34). The mean values for necrosis and apoptosis, respectively, in control single ß-cells (not exposed to cytokines) after 6 days in culture were 14 ± 1% and 15 ± 2% (n = 5). Similar values were observed after 9 days of culture (data not shown).



View larger version (23K):
[in this window]
[in a new window]
 
Figure 4. Prevalence of apoptosis in ß-cells exposed for 6 (A) or 9 (B) days to IL-1ß (50 U/ml), IFN-{gamma} (1000 U/ml), or PIC (100 µg/ml), alone or in combination. The apoptosis index was calculated as described in Materials and Methods. Cell viability was determined with the DNA-binding dyes HO 342 and PI. Data are the mean ± SEM of five experiments. a, P < 0.05 vs. IL-1ß; b, P < 0.05 vs. IFN-{gamma}; c, P < 0.05 vs. PIC; d, P < 0.05 vs. IL-1ß and IFN-{gamma} (by ANOVA).

 


View larger version (21K):
[in this window]
[in a new window]
 
Figure 5. Effect of the iNOS blocker (MA; 1.0 mM) on the prevalence of apoptosis in ß-cells exposed for 6 (A) or 9 (B) days to IL-1ß (50 U/ml), IFN-{gamma} (1000 U/ml), or PIC (100 µg/ml), alone or in combination. The apoptosis index was calculated as described in Materials and Methods. Cell viability was determined with the DNA-binding dyes HO 342 and PI. Data are the mean ± SEM of six experiments. *, P < 0.05 vs. IL plus PIC; #, P < 0.05 vs. IL plus IFN (by ANOVA).

 
Statistical analysis
The results are presented as the mean ± SEM. Statistical differences between the groups were determined by paired Student’s t test or, when indicated, ANOVA, followed by multiple paired or unpaired t tests with the Bonferroni correction.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Cytokine- and PIC-induced mRNA expression
There was a very low expression of Fas or MnSOD mRNA in control ß-cells. PIC or IL-1ß, but not IFN-{gamma}, induced a clear increase in Fas and MnSOD expression (Fig. 1Go). IL-1ß plus PIC induced higher MnSOD expression than that induced by IL-1ß or PIC alone (Fig. 1Go).



View larger version (25K):
[in this window]
[in a new window]
 
Figure 1. A, RT-PCR analysis of Fas, MnSOD, iNOS, MHC class I, Spi-3, and GAPDH mRNA expression by ß-cells exposed for 6 h to control condition (no cytokines added) or to IL-1ß (50 U/ml), IFN-{gamma} (1000 U/ml), or PIC (100 µg/ml), alone or in combination. The cDNA samples were amplified in parallel with GAPDH-specific primers, confirming similar loading in all lanes. The figure is representative of three similar experiments. B, ODs of Fas, MnSOD, iNOS, MHC class I, and Spi-3 mRNA expression, corrected for GAPDH and multiplied by 100 for clarity. The values are the mean ± SEM of three experiments.

 
Control ß-cells or ß-cells exposed to PIC or IFN-{gamma} alone (Fig. 1Go) did not express iNOS. Both IL-1ß alone and PIC plus IFN-{gamma} induced iNOS expression, but PIC failed to potentiate IL-1ß-induced iNOS expression.

PIC did not consistently affect the expression of the mRNAs encoding for MHC class I and serine protease inhibitor 3 (Spi-3; Fig. 1Go). IFN-{gamma} induced MHC class I expression, whereas IL-1 increased the expression of Spi-3 mRNA. These effects of individual cytokines were not potentiated by PIC or the other cytokines. None of the above-described treatments modified the expression of the housekeeping gene GAPDH (Fig. 1Go). The ODs for GAPDH expression were (mean ± SEM of three experiments): control, 1.65 ±0.29; IL-1ß, 1.26 ± 0.14; IFN-{gamma}, 1.34 ± 0.19; PIC, 1.41 ± 0.33; IL-1ß plus PIC, 1.18 ± 0.23; IFN-{gamma} plus PIC, 1.38 ± 0.25; and IL-1ß plus IFN-{gamma}, 1.35 ± 0.28.

As mentioned above, PIC cooperated with IFN-{gamma} to induce iNOS mRNA expression (Fig. 1Go). Sequence analysis and functional studies of the 5'-flanking region of the rat iNOS gene in insulin-producing cells have previously revealed two NF-{kappa}B sites and one GAS site that mediate the stimulatory effects of IL-1ß and IFN-{gamma} (30). To delineate the PIC- plus IFN-{gamma}-responsive regions in the iNOS promoter, transient transfections were performed with the plasmid piNOS-1002luc containing nucleotides -1002 to +132 of the rat iNOS promoter (wt), and mutants from piNOS-1002luc in which either the distal or proximal NF-{kappa}B binding site or the STAT-binding (GAS) site was inactivated. The values for relative luciferase activity were (mean ± SEM of three experiments): wt not exposed to cytokines, 2 ± 1; wt exposed to PIC and IFN-{gamma}, 156 ± 51; and wt exposed to IL-1ß, 101 ± 10. Thus, PIC plus IFN-{gamma} induced a nearly 70-fold increase in iNOS promoter activity, similar to the induction observed in wt constructs exposed to IL-1ß (used as a positive control) (30). Site mutations of the proximal or distal NF-{kappa}B binding sites decreased PIC- plus IFN-{gamma}-induced iNOS promoter activity by 80% (Fig. 2Go), whereas inactivation of GAS lead to a minor and nonsignificant reduction in promoter activity (Fig. 2Go). These data indicate that NF-{kappa}B is a crucial transcription factor for PIC-induced iNOS expression.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 2. Effects of site-directed mutations on iNOS promoter activity after PIC and IFN-{gamma} treatment of ß-cells. Cells were transfected with the piNOS-1002luc (wt) construct described in Materials and Methods or with the same construct but mutated either at the proximal (MpNF-{kappa}B) or the distal (MdNF-{kappa}B) NF-{kappa}B sites or at the GAS site (MSTAT). Data are expressed as a percentage of the relative luciferase activity observed in cells transfected with the wt construct and exposed to IFN-{gamma} and PIC (considered 100% in each experiment; absolute values provided in Results). Results are the mean ± SEM of three experiments. *, P < 0.05; **, P < 0.01 (vs. wt exposed to IFN-{gamma} and PIC, by paired t test).

 
Viability and nitrite production by ß-cells exposed to cytokines and/or PIC
In agreement with the mRNA data (Fig. 1Go), ß-cells exposed for 72 h to IL-1ß presented a 4-fold increase in nitrite production, whereas neither PIC nor IFN-{gamma} alone increased medium nitrite accumulation above basal levels (Fig. 3Go). A combination of PIC and IFN-{gamma} increased nitrite production similarly to that observed with IL-1ß. These levels were significantly higher than those observed in the control condition or after exposure to PIC or IFN-{gamma} alone (P < 0.05). On the other hand, PIC failed to further increase the nitrite production induced by IL-1ß or IL-1ß plus IFN-{gamma}.



View larger version (36K):
[in this window]
[in a new window]
 
Figure 3. Cytokine- and/or PIC-induced nitrite production by ß-cells exposed for 72 h to control conditions ({square}) or to IL-1ß (50 U/ml), IFN-{gamma} (1000 U/ml), or PIC (100 µg/ml), alone or in combination. Results are the mean ± SEM of nine experiments. *, P < 0.01 vs. control (by ANOVA).

 
Exposure of ß-cells to PIC or cytokines alone for 6 or 9 days did not consistently increase the percentage of apoptotic cells (Fig. 4Go and data not shown). Combinations containing IL-1ß and IFN-{gamma}, IL-1ß and PIC, IFN-{gamma} and PIC, or PIC, IL-1ß, and IFN-{gamma} induced a significant increase in the percentage of apoptotic cells after 6 and 9 days when compared against controls (P < 0.001; data not shown) and when compared with individual cytokines or PIC alone (Fig. 4Go). None of the treatments used induced a significant increase in the fraction of necrotic cells (data not shown). These data indicate that PIC synergizes with IL-1ß and/or IFN-{gamma} to induce ß-cell death and that the main form of cell death under the present experimental conditions was apoptosis.

As PIC in combination with cytokines induced iNOS expression (Fig. 1Go), NO production (Fig. 3Go), and ß-cell apoptosis (Fig. 4Go), we next evaluated whether NO production is required for PIC- plus cytokine-induced apoptosis. For this purpose, ß-cells were exposed to different proapoptotic conditions in the presence or absence of the iNOS blocker MA (Fig. 5Go). MA, cytokines, or PIC alone did not modify the percentage of apoptotic cells, and none of the different treatments lead to an increased number of necrotic cells (data not shown). On the other hand, as observed in Fig. 4Go, there was an increase in the apoptotic index after exposure to IL-1ß plus IFN-{gamma}, IL-1ß plus PIC, or IFN-{gamma} plus PIC on both days 6 and 9. MA abolished the apoptosis induced by IL-1ß and PIC and partially protected against apoptosis induced by IL-1ß and IFN-{gamma}, but it did not prevent apoptosis induced by IFN-{gamma} and PIC. As previously described (19) (Pavlovic, D., and D. L. Eizirik, unpublished data), MA prevented the increased NO formation induced by IL-1ß, IL-1ß plus IFN-{gamma}, IL-1ß plus PIC, or IFN-{gamma} plus PIC (data not shown). As a whole, these observations suggest that PIC contributes to cytokine-induced ß-cell apoptosis by both NO-dependent and NO-independent mechanisms.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Viral infections may induce or accelerate the pathogenesis of T1DM through three main mechanisms: 1) direct destruction by virus-induced cytolysis (3, 35); 2) induction of an islet inflammatory reaction and stimulation of putative autoreactive T cells, leading to ß-cell damage (36, 37); and 3) initiation of a ß-cell-targeted autoimmune process by molecular mimicry (38, 39). Recent evidence, using transgene technology, suggests that a cooperation between viral infection and inflammatory response (bystander damage) is probably the most important mechanism for ß-cell destruction in virus-induced experimental diabetes (37, 40). In this scenario, ß-cells would be exposed to both viral products, such as dsRNA, and proinflammatory cytokines, such as IL-1ß and IFN-{gamma} (10, 11, 12, 14).

To further investigate the mechanisms of ß-cell dysfunction/death after exposure to these agents, we presently characterized the effects of PIC alone or in combination with IL-1ß and/or IFN-{gamma} on the gene expression and viability of FACS-purified rat ß-cells. The use of purified ß-cells in the present experiments allows discrimination between necrosis and apoptosis (9, 31, 32, 33) and removes potential biases due to effects of PIC and/or cytokines on non-ß-cells that are usually present in whole islet preparations (41, 42).

PIC induced expression of Fas, MnSOD, and, to a minor extent, MHC class I mRNA. Similarly, IL-1ß induced Fas and MnSOD expression, but it also led to increased expression of two mRNAs not affected by PIC, namely iNOS and Spi-3. On the other hand, IFN-{gamma} did not induce the expression of Fas, MnSOD, iNOS, or Spi3, but this cytokine was the most potent inducer of MHC class I expression. This diverse pattern of mRNA expression triggered by PIC, IL-1ß, and IFN-{gamma} suggests that these agents act on ß-cells at least to some extent by distinct signal transduction pathways. It is noteworthy that the effects of PIC on mRNA expression were more similar to the effects of IL-1ß than to those of IFN-{gamma}. It has been previously shown that IL-1ß triggers the expression of iNOS (30, 43, 44), MnSOD (27), and Fas (Darville, M., and D. L. Eizirik, manuscript in preparation) via NF-{kappa}B activation. IFN-{gamma}, on the other hand, potentiates the effects of IL-1ß on iNOS expression via STAT-1 nuclear binding (30), without affecting IL-1ß-induced NF-{kappa}B activation (45). We presently observed, by site-directed mutagenesis, that two separate NF-{kappa}B-binding sites in the iNOS promoter are required for PIC- and IFN-{gamma}-induced iNOS expression in primary ß-cells. Site mutation of STAT-1 also leads to a decrease, of minor proportion, in iNOS expression. This inhibitory effect of STAT-1 inactivation is probably due to blocking the IFN-{gamma} signal transduction, whereas blocking of NF-{kappa}B probably acts by preventing PIC signaling. Indeed, as mentioned above, IFN-{gamma} does not activate NF-{kappa}B in ß-cells, whereas PIC has been shown in other tissues to affect cellular function via NF-{kappa}B activation (46, 47). The fact that both IL-1ß (30, 43, 44) and PIC (present data) use NF-{kappa}B for signal transduction in ß-cells may explain the similarities between the effects of these agents on mRNA expression in ß-cells.

PIC, in the range of 10–100 µg, has been shown to induce apoptosis in diverse cell types (23, 48, 49). This was not the case for pancreatic ß-cells, where the viral product alone failed to induce cell death. When PIC was combined with either IL-1ß or IFN-{gamma}, however, it led to a significant increase in ß-cell death, mostly by apoptosis. The present finding that apoptosis is the main form of cell death induced by PIC and cytokines in rat ß-cells is in line with previous studies showing that exposure of human, mouse, or rat ß-cells to IL-1ß plus IFN-{gamma} or IL-1ß, IFN-{gamma}, plus tumor necrosis factor-{alpha} induces cell death mostly by apoptosis (22, 26, 31, 32).

As discussed above, a combination of IFN-{gamma} and PIC induced iNOS expression, NO production, and ß-cell death by apoptosis, suggesting a potential link between NO synthesis and ß-cell apoptosis. Indeed, it has been previously suggested that blockage of iNOS activity prevents IFN-{gamma}- and PIC-induced cell death in whole islets (16). We presently observed that the iNOS blocker L-NMMA prevents PIC- plus IFN-{gamma}-induced NO formation, but does not prevent ß-cell death, suggesting that NO is not a major mediator in ß-cell apoptosis induced by PIC and IFN-{gamma}. A possible explanation for the differences between our findings and data reported by Heitmeier et al. (16) is the use of different experimental models, namely whole islets (16) vs. pure ß-cells (present data). NO apparently has a more relevant role for cytokine-induced cell death (mostly by necrosis) in whole islets than in purified ß-cells (22, 32). Moreover, cell death seems to occur earlier in cytokine-exposed whole islets than in pure ß-cells (22, 26). This may be due to the disappearance of intercellular capillary spaces in whole islets maintained in culture, causing central ischemia and allowing local accumulation of high amounts of NO. On the other hand, it cannot be excluded that FACS purification of ß-cells and the consequent loss of cell to cell contacts increases ß-cell susceptibility to proapoptotic stimuli. Moreover, some of the effects of PIC and/or cytokines on ß-cells in whole islets (in vivo and in vitro) may be mediated via islet non-ß-cells, absent in our FACS-purified preparations. Another reason for the difference findings of our report and that by Heitmeier et al. (16) is the lack of quantitative (number of dead cells) and qualitative (apoptosis or necrosis) evaluation of ß-cell death in the study by Heitmeier et al. (16) compared with the present quantitative assessment of ß-cell necrosis/apoptosis.

It is noteworthy that NO seems to play a necessary role for ß-cell apoptosis induced by PIC and IL-1ß (present data), as suggested by the complete protection induced by NG-monomethyl-L-arginine (MA) against these agents. These observations indicate that PIC synergizes with IFN-{gamma} and IL-1ß for the induction of ß-cell apoptosis by different mechanisms, i.e. either by NO-independent (PIC plus IFN-{gamma}) or NO-dependent (PIC plus IL-1ß) processes. The nature of the signal transduction used by PIC and IFN-{gamma} to induce ß-cell apoptosis remains to be clarified.

We presently observed another PIC effect that may contribute to ß-cell apoptosis, the induction of Fas mRNA. The initiation of autoimmune diabetes in mice probably involves Fas ligand (FasL)-Fas mediated apoptosis, i.e. FasL-expressing T lymphocytes may induce cell death in Fas-expressing ß-cells (50, 51, 52, 53). Fas expression was also detected in ß-cells from patients with recent-onset T1DM, whereas FasL was observed in the islet-infiltrating lymphocytes (54).

In conclusion, the present observations suggest that PIC interacts with the cytokines IL-1ß and IFN-{gamma} to induce the expression of ß-cell genes potentially involved in ß-cell dysfunction/death, namely Fas and iNOS. Moreover, the viral product in combination with proinflammatory cytokines leads to ß-cell death by apoptosis. Previous studies have indicated that cytokines are expressed in the vicinity of islet ß-cells during virus-induced diabetes in mice (14). Several viruses can infect human ß-cells (5), and epidemiological data support a role for viral infections in the pathogenesis of human T1DM (3, 4, 55). Taking this and the present data into account, it is conceivable that prolonged infection of ß-cells by viruses leads to local inflammation, with both production of cytokines (such as IL-1ß and IFN-{gamma}) and eventual islet invasion by mononuclear cells expressing FasL. In this context, viral products (e.g. dsRNA) acting in synergism with the locally produced cytokines could contribute to ß-cell death by Fas up-regulation, intracellular NO production, and generation of additional proapoptotic signals whose nature remains to be clarified.


    Acknowledgments
 
The technical assistance of R. Leemans and the Diabetes Research Center personnel involved in ß-cell purification is gratefully acknowledged.


    Footnotes
 
1 This work was supported by grants from the Juvenile Diabetes Foundation International, Fund for Scientific Research Flanders and a Shared Cost Action in Medical and Health Research from the European Community. Back

Received December 19, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Atkinson MA, Maclaren NK 1994 The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428–1436[Free Full Text]
  2. Bach JF 1995 Insulin-dependent diabetes mellitus as a ß-cell targeted disease of immunoregulation. J Autoimmun 8:439–463[CrossRef][Medline]
  3. Yoon JW 1995 A new look at viruses in type 1 diabetes. Diabetes Metab Rev 11:83–107[Medline]
  4. Von Herrath MG, Holz A, Homann D, Oldstone MB 1998 Role of viruses in type I diabetes. Semin Immunol 10:87–100[CrossRef][Medline]
  5. Roivainen M, Rasilainen S, Ylipaasto P, Nissinen R, Ustinov J, Bouwens L, Eizirik DL, Hovi T, Otonkoski T 2000 Mechanisms of coxsackievirus-induced damage to human pancreatic ß-cells. J Clin Endocrinol Metab 85:432–440[Abstract/Free Full Text]
  6. Jacobs BL, Langland JO 1996 When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219:339–349[CrossRef][Medline]
  7. Kibler KV, Shors T, Perkins KB, Zeman CC, Banaszak MP, Biesterfeldt J, Langland JO, Jacobs BL 1997 Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J Virol 71:1992–2003[Abstract]
  8. Mauricio D, Mandrup-Poulsen T 1998 Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes 47: 1537–1543
  9. Eizirik DL, Hoorens A 1999 ß-Cell dysfunction/death. In: Howell S (ed) Advances in Molecular and Cell Biology: The Biology of the Pancreatic ß Cell. JAI Press Stamford, vol 29:47–73
  10. Mandrup-Poulsen T 1996 The role of interleukin-1 in the pathogenesis of insulin-dependent diabetes mellitus. Diabetologia 39:1005–1029[Medline]
  11. Eizirik DL, Pavlovic D 1997 Is there a role for nitric oxide in ß-cell dysfunction and damage in IDDM? Diabetes Metab Rev 13:293–307[CrossRef][Medline]
  12. Rabinovitch A 1998 An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14: 129–151
  13. Eizirik DL, Darville MI 2001 ß-Cell apoptosis and defence mechanisms: lessons from type 1 diabetes. Diabetes [Suppl 1] 50:564–569
  14. Hirasawa K, Jun HS, Maeda K, Kawaguchi Y, Itagaki S, Mikami T, Baek HS, Doi K, Yoon JW 1999 Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol 71:4024–4031[Abstract]
  15. Rhodes CJ, Taylor KW 1985 Effect of interferon and double-stranded RNA on ß-cell function in mouse islets of Langerhans. Biochem J 228:87–94[Medline]
  16. Heitmeier MR, Scarim AL, Corbett JA 1999 Double-stranded RNA inhibits ß-cell function and induces islet damage by stimulating ß-cell production of nitric oxide. J Biol Chem 274:12531–12536[Abstract/Free Full Text]
  17. Pipeleers DG, In’t Veld PA, Van de Winkel M, Maes E, Schuit FC, Gepts W 1985 A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117:806–816[Abstract]
  18. Ling Z, Hannaert JC, Pipeleers D 1994 Effects of nutrients, hormones and serum on survival of rat islet ß-cells in culture. Diabetologia 37:15–21[Medline]
  19. Ling Z, Chen M-C, Smismans A, Pavlovic D, Schuit F, Eizirik DL, Pipeleers DG 1998 Intercellular differences in interleukin-1ß-induced suppression of insulin synthesis and stimulation of noninsulin protein synthesis by rat pancreatic ß-cells. Endocrinology 139:1540–1545[Abstract/Free Full Text]
  20. Chen M-C, Schuit F, Eizirik DL 203 1999 Identification of IL-1ß-induced messenger RNAs in rat pancreatic ß cells by differential display of messenger RNA. Diabetologia 42:1199–1191[CrossRef][Medline]
  21. Ling Z, Van de Casteele M, Eizirik DL, Pipeleers DG 2000 Interleukin-1ß-induced alteration in a ß-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes 49:340–345[Abstract]
  22. Liu D, Pavlovic D, Chen MC, Flodström M, Sandler S, Eizirik DL 2000 Cytokines induce apoptosis in ß-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes 49:1116–1122[Abstract]
  23. Tang NM, Korth MJ, Gale M Jr, Wambach M, Der SD, Bandyopadhyay SK, Williams BR, Katze MG 1999 Inhibition of double-stranded RNA- and tumor necrosis factor {alpha}-mediated apoptosis by tetratricopeptide repeat protein and co-chaperone P58(IPK). Mol Cell Biol 19:4757–4765[Abstract/Free Full Text]
  24. Uetani K, Der SD, Zamanian-Daryoush M, de La Motte C, Lieberman BY, Williams BR, Erzurum SC 2000 Central role of double-stranded RNA-activated protein kinase in microbial induction of nitric oxide synthase. J Immunol 165:988–996[Abstract/Free Full Text]
  25. Green LC, Wagner DA, Goglowski J, Skipper PL, Wishnok JS, Tannenbaum SR 1982 Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131–138[CrossRef][Medline]
  26. Pavlovic D, Chen M-C, Gysemans CA, Mathieu C, Eizirik DL 1999 The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic ß-cells. Eur Cytokine Network 10:403–411[Medline]
  27. Darville MI, Ho YS, Eizirik DL 2000 NF-{kappa}B is required for cytokine-induced manganese superoxide dismutase expression in insulin-producing cells. Endocrinology 141:153–162[Abstract/Free Full Text]
  28. Chen MC, Schuit F, Pipeleers DG, Eizirik DL 1999 IL-1ß induces serine protease inhibitor 3 (SPI-3) gene expression in pancreatic ß-cells. Detection by differential display of messenger RNA. Cytokine 11:856–62[CrossRef][Medline]
  29. Eizirik DL, Björklund A, Cagliero E 1993 Genotoxic agents increase expression of growth arrest and DNA damage inducible genes GADD 153 and GADD 45 in rat pancreatic islets. Diabetes 42:738–745[Abstract]
  30. Darville MI, Eizirik DL 1998 Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells. Diabetologia 41:1101–1108[CrossRef][Medline]
  31. Delaney CA, Pavlovic D, Hoorens A, Pipeleers DG, Eizirik DL 1997 Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138:2610–2614[Abstract/Free Full Text]
  32. Hoorens A 1999 Distinction between Necrosis and Apoptosis of Pancreatic ß Cells. PhD Thesis, Faculty of Medicine and Pharmacy, Vrije University Brussel, Brussels, Belgium
  33. Hoorens A, Van de Casteele M, Kloppel G, Pipeleers D 1996 Glucose promotes survival of rat pancreatic ß-cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 98:1568–1574[Medline]
  34. Pipeleers D, Van de Winkel M 1986 Pancreatic ß cells possess defence mechanisms against cell-specific toxicity. Proc Natl Acad Sci USA 83:5267–5271[Abstract/Free Full Text]
  35. Yoon JW, Austin M, Onodera T, Notkins AL 1979 Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300:1173–1179[Abstract]
  36. Gerling I, Chatterjee NK 1990 Autoantigen (64000-Mr) expression in coxsackievirus B4-induced experimental diabetes. Curr Top Microbiol Immunol 156:55–62[Medline]
  37. Horwitz MS, Sarvetnick N 1999 Viruses, host responses, and autoimmunity. Immunol Rev 169:241–253[CrossRef][Medline]
  38. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ 1992 Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 89:283–292
  39. Lonnrot M, Hyoty H, Knip M, Roivainen M, Kulmala P, Leinikki P, Akerblom HK 1996 Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of coxsackievirus B4. Clin Exp Immunol 104:398–405[CrossRef][Medline]
  40. Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N 1998 Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 4:781–785[CrossRef][Medline]
  41. Arnush M, Scarim AL, Heitmeier MR, Kelly CB, Corbett JA 1998 Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J Immunol 160:2684–2691[Abstract/Free Full Text]
  42. Pavlovic D, Chen M-C, Bouwens L, Eizirik DL, Pipeleers D 1999 Contribution of ductal cells to cytokine responses by human pancreatic islets. Diabetes 48:29–33[Abstract]
  43. Saldeen J, Welsh N 203 1994 Interleukin-1 ß induced activation of NF-{kappa}B in insulin producing RINm5F cells is prevented by the protease inhibitor N-{alpha}-p-tosyl-L-lysine chloromethylketone. Biochem Biophys Res Commun 149–155
  44. Bedoya FJ, Flodström M, Eizirik DL 1995 Pyrrolidine dithiocarbamate prevents IL-1-induced nitric oxide synthase mRNA, but not superoxide dismutase mRNA, in insulin producing cells. Biochem Biophys Res Commun 210:816–822[CrossRef][Medline]
  45. Flodström M, Eizirik DL 1997 Interferon-{gamma}-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production. Endocrinology 138:2747–2753[Abstract/Free Full Text]
  46. Kumar A, Haque J, Lacoste J, Hiscott J, Williams BR 1994 Double-stranded RNA-dependent protein kinase activates transcription factor NF-{kappa}B by phosphorylating I {kappa}B. Proc Natl Acad Sci USA 91:6288–6292[Abstract/Free Full Text]
  47. Gil J, Alcami J, Esteban M 1999 Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the {alpha} subunit of eukaryotic translation initiation factor 2 and NF-{kappa}B. Mol Cell Biol 19:4653–4663[Abstract/Free Full Text]
  48. Balachandran S, Kim CN, Yeh WC, Mak TW, Bhalla K, Barber GN 1998 Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO. J 17:6888–6902
  49. Kaufman RJ 1999 Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor. Proc Natl Acad Sci USA 96:11693–11695[Free Full Text]
  50. Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway Jr CA, Matis LA 1997 The role of Fas in autoimmune diabetes. Cell 89:17–24[CrossRef][Medline]
  51. Itoh N, Imagawa A, Hanafusa T, Waguri M, Yamamoto K, Iwahashi H, Moriwaki M, Nakajima H, Miyagawa J, Namba M, Makino S, Nagata S, Kono N, Matsuzawa Y 1997 Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J Exp Med 186:613–618[Abstract/Free Full Text]
  52. Amrani A, Verdaguer J, Anderson B, Utsugi T, Bou S, Santamaria P 1999 Perforin-independent ß-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice. J Clin Invest 103:1201–1[Medline]
  53. Suarez-Pinzon W, Sorensen O, Bleackley RC, Elliott JF, Rajotte RV, Rabinovitch A 1999 ß-cell destruction in NOD mice correlates with Fas (CD95) expression on ß-cells and proinflammatory cytokine expression in islets. Diabetes 48:21–28[Abstract]
  54. Moriwaki M, Itoh N, Miyagawa J, Yamamoto K, Imagawa A, Yamagata K, Iwahashi H, Nakajima H, Namba M, Nagata S, Hanafusa T, Matsuzawa Y 1999 Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset type I diabetes mellitus. Diabetologia 42:1332–1340[CrossRef][Medline]
  55. Dahlquist G, Frisk G, Ivarsson SA, Svanberg L, Forsgren M, Diderholm H 1995 Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM. Diabetologia 38:1371–1373[Medline]



This article has been cited by other articles:


Home page
DiabetesHome page
Z. Dogusan, M. Garcia, D. Flamez, L. Alexopoulou, M. Goldman, C. Gysemans, C. Mathieu, C. Libert, D. L. Eizirik, and J. Rasschaert
Double-Stranded RNA Induces Pancreatic {beta}-Cell Apoptosis by Activation of the Toll-Like Receptor 3 and Interferon Regulatory Factor 3 Pathways
Diabetes, May 1, 2008; 57(5): 1236 - 1245.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Rasschaert, L. Ladriere, M. Urbain, Z. Dogusan, B. Katabua, S. Sato, S. Akira, C. Gysemans, C. Mathieu, and D. L. Eizirik
Toll-like Receptor 3 and STAT-1 Contribute to Double-stranded RNA+ Interferon-{gamma}-induced Apoptosis in Primary Pancreatic {beta}-Cells
J. Biol. Chem., October 7, 2005; 280(40): 33984 - 33991.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Yamazaki, H. Akiba, A. Koyanagi, M. Azuma, H. Yagita, and K. Okumura
Blockade of B7-H1 on Macrophages Suppresses CD4+ T Cell Proliferation by Augmenting IFN-{gamma}-Induced Nitric Oxide Production
J. Immunol., August 1, 2005; 175(3): 1586 - 1592.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Augstein, P. Heinke, E. Salzsieder, S. Berg, R. Rettig, C. Salzsieder, and L. C. Harrison
Fas Ligand Down-Regulates Cytokine-Induced Fas Receptor Expression on Insulinoma (NIT-1), But Not Islet Cells, from Autoimmune Nonobese Diabetic Mice
Endocrinology, June 1, 2004; 145(6): 2747 - 2752.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. E. Thomas, W. Irawaty, R. Darwiche, T. C. Brodnicki, P. Santamaria, J. Allison, and T. W.H. Kay
IL-1 Receptor Deficiency Slows Progression to Diabetes in the NOD Mouse
Diabetes, January 1, 2004; 53(1): 113 - 121.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Kutlu, A. K. Cardozo, M. I. Darville, M. Kruhoffer, N. Magnusson, T. Orntoft, and D. L. Eizirik
Discovery of Gene Networks Regulating Cytokine-Induced Dysfunction and Apoptosis in Insulin-Producing INS-1 Cells
Diabetes, November 1, 2003; 52(11): 2701 - 2719.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. A. Robbins, L. Maksumova, E. Pocock, and J. K. Chantler
Nuclear Factor-{kappa}B Translocation Mediates Double-Stranded Ribonucleic Acid-Induced NIT-1 {beta}-Cell Apoptosis and Up-Regulates Caspase-12 and Tumor Necrosis Factor Receptor-Associated Ligand (TRAIL)
Endocrinology, October 1, 2003; 144(10): 4616 - 4625.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Kutlu, M. I. Darville, A. K. Cardozo, and D. L. Eizirik
Molecular Regulation of Monocyte Chemoattractant Protein-1 Expression in Pancreatic {beta}-Cells
Diabetes, February 1, 2003; 52(2): 348 - 355.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Liu, A. K. Cardozo, M. I. Darville, and D. L. Eizirik
Double-Stranded RNA Cooperates with Interferon-{gamma} and IL-1{beta} to Induce Both Chemokine Expression and Nuclear Factor-{kappa}B-Dependent Apoptosis in Pancreatic {beta}-Cells: Potential Mechanisms for Viral-Induced Insulitis and {beta}-Cell Death in Type 1 Diabetes Mellitus
Endocrinology, April 1, 2002; 143(4): 1225 - 1234.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Cardozo, H. Heimberg, Y. Heremans, R. Leeman, B. Kutlu, M. Kruhoffer, T. Orntoft, and D. L. Eizirik
A Comprehensive Analysis of Cytokine-induced and Nuclear Factor-kappa B-dependent Genes in Primary Rat Pancreatic beta -Cells
J. Biol. Chem., December 21, 2001; 276(52): 48879 - 48886.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, D.
Right arrow